Industry Documents Library

We also posted a guide about Endo's 2017 withdrawal of “crush-resistant” Opana ER from the market, due to public health concerns. Read more: https://www.industrydocuments.ucsf.edu/opioids/more-resources/endo-documents--opanaer-market-withdrawal/
Industry Documents Library

And we shared a guide about PBM Medco (now part of Express Scripts) and their relationship with Purdue: https://www.industrydocuments.ucsf.edu/opioids/more-resources/pharmacy-benefit-manager-collection--pbm-medco-partners-purdue/
Industry Documents Library